Conifer Point Pharmaceuticals

Executive Summary

Conifer Point Pharmaceuticals was a Cambridge-based biotechnology company that specialized in applying advanced computational tools and services to assist drug discovery researchers in designing and improving early-stage compounds, particularly for challenging targets. The company offered a combination of expert consulting and industry-standard computational chemistry services, including its core technology, the Boltzmann Maps web application, for small molecule design and prioritization in pre-clinical discovery. Founded in 2013, the company operated at the pre-clinical stage as a private entity, but its description uses past tense, suggesting it may have ceased operations or been acquired. With no recent funding, partnerships, or pipeline updates, the company appears to be inactive, making it an unlikely candidate for near-term investment.